General Information of the Compound
Compound ID
CP0456876
Compound Name
4-[5-(1-tert-butyl-4,5,6,7-tetrahydrobenzotriazol-5-yl)-1,2,4-oxadiazol-3-yl]morpholine
    Show/Hide
Structure
Formula
C16H24N6O2
Molecular Weight
332.408
Canonical SMILES
CC(C)(C)n1nnc2CC(CCc12)c1nc(no1)N1CCOCC1
    Show/Hide
InChI
InChI=1S/C16H24N6O2/c1-16(2,3)22-13-5-4-11(10-12(13)18-20-22)14-17-15(19-24-14)21-6-8-23-9-7-21/h11H,4-10H2,1-3H3
    Show/Hide
InChIKey
DOMGNCULJRFQNG-UHFFFAOYSA-N
Physicochemical Property
logP
1.5252
Rotatable Bonds
2
Heavy Atom Count
24
Polar Areas
82.1
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
8
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 127034896
ChEMBL ID
CHEMBL3735297
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00854, Metabotropic glutamate receptor 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000043 U2OS Homo sapiens (Human)  1
1
EC50 = 1258.93 nM
   TI
   LI
   LO
   TS